ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

Drug Development Gets Extra $500,000

November 18, 1977

Greenwald Lists Items Missing Because Not Enough Money Available

November 25, 1988

In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches

September 3, 1976

In Brief: Maguire Wants Five Environmental Experts In Addition To Those On The Board

February 16, 1979

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979